Le Lézard
Classified in: Health, Business
Subject: PER

Global Diagnostics Leader Joins Health Care Firm


CHICAGO, March 3, 2021 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that Brian Blaser has joined the firm as an executive advisor.  Mr. Blaser joins Water Street following his retirement from Abbott Laboratories, where he oversaw the health care company's $8.5 billion global diagnostics organization, including its core laboratory, point of care, rapid diagnostics and molecular diagnostics businesses. 

During his 15-year tenure with Abbott, Mr. Blaser was instrumental in growing the diagnostics organization.  He spearheaded the development and launch of the Alinity family of instruments and reagents and the company's acquisition of Alere, which transformed Abbott into the global leader in point-of-care and rapid diagnostic testing.  Prior to Abbott, Mr. Blaser held key leadership positions in operations, finance and engineering with the Ortho-Clinical Diagnostics division of Johnson & Johnson, Eastman Kodak and General Motors. 

"I have long admired Water Street's team for their singular focus on health care and investments that improve patient outcomes and contribute to a better health care system," said Mr. Blaser.  "I am looking forward to working with the team as we seek to identify and create transformational opportunities in diagnostics and medical devices that make a positive impact for patients, providers and our investors."

Mr. Blaser serves on the board of trustees for Cristo Rey St. Martin College Prep and as the chair of the Engineering Advisory Council for the University of Dayton.  He is a former member of the board of the Advanced Medical Technology Association (AdvaMed).  Mr. Blaser received a master's in business administration from the Rochester Institute of Technology and a bachelor's degree in mechanical engineering technology from the University of Dayton.

Mr. Blaser will work with Water Street's team of former health care executives and senior investment professionals to identify and pursue growth opportunities in diagnostic products and services.  Water Street has completed more than 120 investments and strategic acquisitions to build 35+ market-leading health care companies in the past decade. The firm is actively pursuing opportunities to grow companies in three key health care sectors: health care services, medical products and diagnostics, and pharmaceuticals and life sciences.

About Water Street

Water Street is a strategic investor focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. It has worked with some of the world's leading companies on its investments including Humana, Johnson & Johnson, Medtronic and Walgreen Co. Water Street's team is comprised of industry executives and investment professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago.

WS Website 

WS News Subscription 

WS LinkedIn

 

SOURCE Water Street Healthcare Partners


These press releases may also interest you

at 01:26
Rickard Gustafson, President and CEO: "Our first quarter performance marked another step towards a more resilient and competitive SKF. In soft market conditions, we delivered a strong adjusted operating margin of 13.4%, somewhat ahead of Q1 2023. The...

at 01:15
The first-ever public auction of the epic satoshi held by CoinEx, the leading global cryptocurrency exchange, ended on April 25, 2024, at 16:00 (UTC). As the first example shown in history, the auction attracted global users for 35 bids, and the epic...

25 avr 2024
AZZ Inc. , the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the pricing of its underwritten public offering of 4,000,000 shares of common stock at a public offering price per share of $70.00, for...

25 avr 2024
CarLotz, Inc.  Accused of Misleading Investors On March 29, 2024, the defendants' motion to dismiss in the pending securities class...

25 avr 2024
TSX VENTURE COMPANIES BULLETIN V2024-1200 LEONOVUS INC. ("LTV.WT")BULLETIN TYPE:  Warrant Expiry-DelistBULLETIN DATE:  April 25, 2024TSX Venture Tier 2 Company Effective at the opening, May 2, 2024, the Share Purchase Warrants of the Company will...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....



News published on and distributed by: